In vitro dissolution method for evaluation of buprenorphine in situ gel formulation: A technical note
AUTOR(ES)
Graves, Richard A.
FONTE
Springer-Verlag
RESUMO
The in situ gel formulation of buprenorphine showed sustained drug release for a prolonged period of time. The drug release from RG 502 followed a linear pattern throughout the dissolution without any significant burst release. The amount of buprenorphine released during the first 30 minutes, irrespective of the type of Resomer or dissolution medium, was less than 3%. Drug release continued over 55 days in phosphate buffer and 35 days in Tween 80. The in vitro dissolution method developed during this study was capable of identifying formulation differences and thus will be useful for routine drug delivery research, particularly in situ gel formulation development research. In situ gel formulations are routinely compared using animal models,21, so development of such an in vitro method will expedite formulation evaluation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2750558Documentos Relacionados
- Bioavailability assessment of ketoprofen incorporated in gelled self-emulsifying formulation: A technical note
- Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: A technical note
- Green tea in transdermal formulation: HPLC method for quality control and in vitro drug release assays
- Evaluation of polymerized rosin for the formulation and development of transdermal drug delivery system: A technical note
- Gauge repeatability and reproducibility for accessing variability during dissolution testing: A technical note
